Ginkgo Bioworks Announces Nomination of Myrtle Potter and Ross Fubini to Board of Directors
And I could not be more grateful to Marijn and Reshma for their leadership and guidance over this truly evolutionary period for Ginkgo.
- And I could not be more grateful to Marijn and Reshma for their leadership and guidance over this truly evolutionary period for Ginkgo.
- Myrtle Potter brings over 25 years of experience leading and advising global technology and life sciences companies and serving on public company boards.
- Until recently, Ms. Potter served as President, Chief Executive Officer, and Chair of the board of Sumitomo Pharma America.
- Ross Fubini founded XYZ Venture Capital, a venture capital investment firm, in 2017, and serves as Managing Director.